Garde Capital’s Thermo Fisher Scientific TMO Stock Holding History

Garde Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-306	Closed	-$124K	–	751
2025 Q2	$124K	Hold	306	–	–	0.01%	260
2025 Q1	$152K	Sell	306 -5	-2%	-$2.71K	0.01%	237
2024 Q4	$162K	Hold	311	–	–	0.01%	224
2024 Q3	$192K	Hold	311	–	–	0.01%	212
2024 Q2	$172K	Hold	311	–	–	0.01%	220
2024 Q1	$180K	Sell	311 -29	-9%	-$16.3K	0.01%	217
2023 Q4	$180K	Buy	340 +17	+5%	+$8.23K	0.01%	213
2023 Q3	$163K	Sell	323 -21	-6%	-$11.2K	0.01%	213
2023 Q2	$179K	Hold	344	–	–	0.01%	226
2023 Q1	$198K	Sell	344 -15	-4%	-$8.45K	0.02%	182
2022 Q4	$198K	Buy	359 +15	+4%	+$7.95K	0.02%	178
2022 Q3	$174K	Hold	344	–	–	0.02%	179
2022 Q2	$187K	Sell	344 -15	-4%	-$8.26K	0.02%	189
2022 Q1	$212K	Buy	359 +15	+4%	+$8.62K	0.02%	189
2021 Q4	$230K	Hold	344	–	–	0.02%	200
2021 Q3	$197K	Hold	344	–	–	0.02%	203
2021 Q2	$174K	Hold	344	–	–	0.02%	216
2021 Q1	$157K	Hold	344	–	–	0.02%	208
2020 Q4	$160K	Buy	+344	New	+$161K	0.02%	200

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Garde Capital's TMO Position: Q3 2025 in Review

Garde Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 306 shares — an estimated $124K sold.

Garde Capital first reported a position in TMO in Q4 2020 and held it in 19 quarters. The position peaked at $230K in Q4 2021. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Garde Capital reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 306 Thermo Fisher Scientific shares in Q3 2025, an estimated $124K.
Garde Capital first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 19 quarters.
Garde Capital's Thermo Fisher Scientific position peaked at $230K in Q4 2021.
2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.